Amedisys Inc (AMED)
90.58
-0.47
(-0.52%)
USD |
NASDAQ |
Apr 25, 09:50
Amedisys SG&A Expense (Quarterly): 199.70M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 199.70M |
September 30, 2023 | 192.98M |
June 30, 2023 | 212.99M |
March 31, 2023 | 194.56M |
December 31, 2022 | 193.43M |
September 30, 2022 | 188.34M |
June 30, 2022 | 187.82M |
March 31, 2022 | 184.47M |
December 31, 2021 | 184.85M |
September 30, 2021 | 178.93M |
June 30, 2021 | 175.22M |
March 31, 2021 | 172.24M |
December 31, 2020 | 175.60M |
September 30, 2020 | 179.62M |
June 30, 2020 | 156.34M |
March 31, 2020 | 156.74M |
December 31, 2019 | 156.06M |
September 30, 2019 | 154.71M |
June 30, 2019 | 152.30M |
March 31, 2019 | 144.85M |
December 31, 2018 | 132.32M |
September 30, 2018 | 124.54M |
June 30, 2018 | 123.09M |
March 31, 2018 | 121.36M |
December 31, 2017 | 123.67M |
Date | Value |
---|---|
September 30, 2017 | 118.88M |
June 30, 2017 | 120.92M |
March 31, 2017 | 118.75M |
December 31, 2016 | 124.84M |
September 30, 2016 | 124.43M |
June 30, 2016 | 126.66M |
March 31, 2016 | 127.50M |
December 31, 2015 | 120.27M |
September 30, 2015 | 112.60M |
June 30, 2015 | 115.56M |
March 31, 2015 | 104.01M |
December 31, 2014 | 104.27M |
September 30, 2014 | 103.18M |
June 30, 2014 | 107.99M |
March 31, 2014 | 126.30M |
December 31, 2013 | 116.85M |
September 30, 2013 | 115.87M |
June 30, 2013 | 117.61M |
March 31, 2013 | 123.74M |
December 31, 2012 | 128.89M |
September 30, 2012 | 126.76M |
June 30, 2012 | 130.91M |
March 31, 2012 | 133.95M |
December 31, 2011 | 115.14M |
September 30, 2011 | 134.95M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
152.30M
Minimum
Jun 2019
212.99M
Maximum
Jun 2023
178.78M
Average
179.62M
Median
Sep 2020
SG&A Expense (Quarterly) Benchmarks
Chemed Corp | 105.88M |
Regional Health Properties Inc | 0.786M |
Addus HomeCare Corp | 60.77M |
OptimizeRx Corp | 12.89M |
Option Care Health Inc | 154.74M |